A new research center in Victoria, Australia, will use digitization and artificial intelligence (AI) to advance manufacturing capabilities.
The research project is a joint initiative between the University of Melbourne and CSL, the world’s third-largest biotech company, which treats rare and serious diseases as well as influenza prevention. The initiative also is receiving funding support from State Government’s Victorian Higher Education State Investment Fund. The University of Melbourne’s Faculty of Engineering and Information Technology will run the program, which will be led by Professor Sally Gras.
“The center will connect engineering and computing specialists with biopharmaceutical and food industries with the aim to improve manufacturing in Victoria through state-of-the-art research solutions,” Gras said.
CSL Executive Director of Bioprocess Development Matthias Zimmermann applauded the partnership and its commitment to research in Australia.
“In addition to showing our commitment to the long-standing partnership CSL has with the University of Melbourne, this funding underscores our important promise to foster a thriving medical research community in Australia and around the world,” he said. “This jointly funded initiative will advance local bioprocess engineering and digital capabilities to support the growth and transformation of Australian manufacturing.”
